V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017577 | 160035099 | 1.52 | 62.2 | Curative (C) | 2013-05-13 | 2013-05-15 | CODOX M | y | N | 160026771 | CODOX M |
| 280004457 | 280007561 | 1.5 | 61.7 | Curative (C) | null | 2015-05-16 | Carboplatin AUC 2 - 5 | y | N | 280027375 | CARBOPLATIN |
| 160032676 | 160017205 | 1.18 | 17.1 | Neo-adjuvant (N) | 2014-05-12 | 2014-05-12 | ALL UKALL2011 IndB Std Dex (PegAsp) | y | N | 160023889 | UKALL2011 |
| 160032722 | 160027760 | 0.95 | 64 | Curative (C) | 2018-08-03 | 2018-08-04 | ALL UKALL2011 Del Int C Recon PAsp | y | null | 160024085 | UKALL2011 |
| 160032763 | 160033343 | 1.9 | 65.6 | Curative (C) | 2014-05-20 | 2014-06-21 | ALL UKALL2011 Ind B Sht Dex (PAsp) | y | N | 160024243 | UKALL2011 |
| 160032773 | 160027818 | 0 | 87 | Curative (C) | 2017-08-26 | 2017-10-29 | ALL UKALL2011 Aug BFM Cons C PegAsp | y | null | 160024268 | UKALL2011 |
| 160035989 | 160017241 | 0.95 | 64 | Palliative (P) | 2017-02-18 | 2017-02-18 | ALL UKALL2011 Aug BFM Cons C PegAsp | y | null | 160023970 | UKALL2011 |
| 160037769 | 160027623 | 0 | 35.9 | Curative (C) | 2018-05-29 | 2018-05-29 | ALL UKALL2011 Maintenance C1 | y | N | 160023574 | UKALL2011 |
| 210038686 | 210037812 | null | 57.2 | Curative (C) | 2015-12-22 | 2016-08-08 | ALL UKALL2011 TRIAL | y | N | 210008526 | UKALL 2011 |
| 210032132 | 210006419 | 0 | null | Curative (C) | null | 2016-02-08 | ALL UKALL2011 Del Int B Pt1 (PAsp) | y | N | 210010026 | UKALL2011 |
| 210029450 | 210007667 | 0 | 10.4 | Palliative (P) | 2013-10-25 | 2013-11-22 | ALL UKALL2011 Maintenance A2 | y | N | 210013789 | UKALL 2011 |
| 210013119 | 210003971 | 1.79 | 0 | Disease modification (D) | null | 2015-07-17 | Abiraterone | y | N | 210041380 | FEC + DOCETAXEL |
| 210017308 | 210007690 | null | 12.5 | Curative (C) | 2017-04-17 | 2017-05-07 | ALL UKALL2011 Del Intens B Pt2 | y | null | 210013846 | UKALL2011 |
| 160027131 | 160017623 | 1.51 | 31.3 | Curative (C) | 2016-06-15 | 2016-07-31 | ALL UKALL2011 Cap Int Maint C PAsp | y | N | 160024757 | UKALL2011 |
| 210018011 | 210009243 | null | 15.9 | Curative (C) | 2017-11-14 | 2017-12-20 | ALL UKALL2011 Consolidation A | y | null | 210018139 | UKALL 2011 |
| 210035727 | 210007968 | 1.83 | 141.9 | Curative (C) | 2016-04-02 | 2016-09-01 | UKALL14- Cons Cycle 1 | y | N | 210014450 | UKALL2014 |
| 210018670 | 210010082 | null | 74 | Curative (C) | 2013-05-07 | 2013-06-08 | UKALL14- Ph 1 Induction + Imatinib | y | N | 210020935 | UKALL2014 |
| 210018707 | 210010124 | 1.73 | 52 | Curative (C) | null | 2016-05-02 | UKALL14- Cons Cycle 1 | y | N | 210021081 | UKALL2014 |
| 210018754 | 210010186 | 1.46 | 67 | Curative (C) | 2018-06-07 | 2018-06-08 | UKALL14- Ph 2 Induction | y | N | 210021303 | UKALL2014 |
| 210018760 | 210010193 | 1.85 | 86.8 | null | 2013-09-22 | 2013-09-30 | UKALL14- Ph 2 Induction | y | null | 210021342 | UKALL2014 |
| 210018933 | 210010387 | 1.87 | 68.4 | Curative (C) | null | 2017-09-28 | UKALL14- Intens/CNS Proph +Imatinib | y | null | 210022230 | UKALL2014 |
| 210025520 | 210009540 | 1.71 | 71.1 | Curative (C) | 2013-12-29 | 2013-12-29 | UKALL14- Ph 2 Induction | y | N | 210019063 | UKALL2014 |
| 210025541 | 210009573 | 1.63 | 61 | Curative (C) | 2016-03-26 | 2016-06-29 | UKALL14- Intens/CNS Proph | y | N | 210019133 | UKALL2014 |
| 210025598 | 210009654 | 1.75 | 74.6 | Curative (C) | null | 2015-02-22 | UKALL14- Intens/CNS Proph +Imatinib | y | null | 210019402 | UKALL2014 |
| 210025672 | 210009763 | 1.58 | 62.7 | Curative (C) | 2013-08-27 | 2013-10-29 | UKALL14- Intens/CNS Proph | y | N | 210019803 | UKALL2014 |
| 210025700 | 210009803 | 1.66 | 74.6 | Curative (C) | 2013-03-07 | 2013-03-07 | UKALL14- Ph 2 Induction | y | null | 210019915 | UKALL2014 |
| 210029070 | 210006368 | 1.08 | 26.9 | Curative (C) | 2015-05-22 | 2015-07-17 | ALL UKALL2011 Std Int Maint A | y | N | 210009866 | UKALL2011 |
| 210029222 | 210006858 | 0 | 10.3 | Curative (C) | 2016-10-29 | 2016-12-20 | ALL UKALL2011 Std Int Maint A | y | N | 210011220 | UKALL2011 |
| 210032666 | 210008735 | 1.65 | 0 | null | 2017-02-02 | 2017-09-15 | UKALL14- Intens/CNS Proph | y | N | 210016266 | UKALL2014 |
| 210029587 | 210008238 | null | 37.2 | Palliative (P) | 2013-02-04 | 2013-08-16 | ALL UKALL2011 TRIAL | y | N | 210015004 | UKALL 2011 |
| 210018627 | 210010024 | 1.83 | 76.7 | Not known (9) | 2016-11-30 | 2016-12-04 | UKALL14- Maintenance | y | N | 210020738 | UKALL2014 |
| 30010491 | 30006667 | 0 | 0 | Palliative (P) | null | 2014-08-12 | STAMPEDE TRIAL | y | N | 30170449 | STAMPEDE TRIAL |
| 20057513 | 20025230 | 1.77 | 67.1 | Palliative (P) | 2017-07-05 | 2017-07-17 | Trial Unspecified | y | N | 20202318 | TRIAL |
| 280004678 | 280003178 | 1.8 | 46.2 | Curative (C) | 2017-02-26 | 2017-02-26 | EW EuroEwing 2012 Arm B VDC | y | N | 280027762 | TRIAL |
| 330002454 | 330001363 | 1.6 | 0 | Palliative (P) | 2016-09-04 | 2016-09-04 | Carboplatin + Paclitaxel (3 weekly) | y | Y | 330009124 | CARBOPLATIN + PACLITAXEL |
| 330002931 | 330001571 | null | 4 | Palliative (P) | 2016-09-14 | 2016-09-15 | Bendamustine+Rituximab (1st Course) | y | Y | 330011813 | BENDAMUSTINE + RITUXIMAB |
| 330008767 | 330005561 | null | 71.2 | Palliative (P) | null | 2015-12-19 | ECX | y | N | 330021319 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330010674 | 330005423 | 0 | 38.4 | Curative (C) | 2017-10-15 | 2018-02-08 | CISPLATIN + EPIRUBICIN | y | N | 330020306 | CARBOPLATIN + VINCRISTINE |
| 20057780 | 20025367 | 2 | 80.9 | Palliative (P) | 2015-07-12 | 2015-07-12 | Trial Unspecified | y | N | 20203267 | TRIAL |
| 220012934 | 220007381 | 1.66 | 101.7 | Curative (C) | 2017-01-04 | 2017-01-04 | Trial Unspecified | y | null | 220028490 | TRIAL |
| 220013378 | 220007783 | 0 | 101.6 | Disease modification (D) | 2014-06-11 | 2014-07-13 | Hydrocortisone Intrathecal(any age) | y | N | 220029966 | NOT MATCHED |
| 220016577 | 220020782 | null | 65.1 | Curative (C) | 2013-12-06 | 2014-02-21 | Trial Unspecified | y | N | 220025320 | TRIAL |
| 220016612 | 220006650 | 1.65 | 74.6 | null | 2018-04-12 | 2018-05-18 | Trial Unspecified | y | N | 220025487 | TRIAL |
| 220016622 | 220013651 | 1.64 | 110.9 | Curative (C) | 2013-07-21 | 2013-07-27 | Trial Unspecified | y | N | 220025532 | TRIAL |
| 220016773 | 220006889 | 1.64 | 52.4 | Curative (C) | 2014-06-11 | 2014-07-08 | AML 19 TRIAL | y | N | 220026397 | AML19 TRIAL |
| 220019137 | 220006653 | null | null | Palliative (P) | 2016-12-15 | 2017-04-21 | Hydroxycarbamide | y | N | 220025491 | HYDROXYCARBAMIDE |
| 210017819 | 210008981 | 1.3 | 10.3 | Curative (C) | 2016-10-09 | 2016-11-19 | ALL UKALL2011 IndB Std Dex (PegAsp) | y | N | 210017164 | UKALL2011 |
| 200029549 | 200014354 | 0.95 | 64.9 | Curative (C) | 2017-03-11 | 2017-04-22 | null | n | N | 200028982 | NOT MATCHED |
| 200019763 | 200009543 | 1.4 | 82.8 | Disease modification (D) | null | 2018-11-17 | Bortezomib + CYCLOPHOSPHAMIDE | n | N | 200011866 | CVD |
| 200019031 | 200008908 | 1.8 | 81.8 | Disease modification (D) | null | 2016-09-01 | Bortezomib + CYCLOPHOSPHAMIDE | n | N | 200009607 | CVD |